{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:30:59Z","timestamp":1773351059321,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82472715"],"award-info":[{"award-number":["82472715"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Plan Project of China","award":["2022YFC2705000"],"award-info":[{"award-number":["2022YFC2705000"]}]},{"name":"Medical-engineering Crossing Research Program of the Shanghai Jiao Tong University","award":["YG2023ZD11"],"award-info":[{"award-number":["YG2023ZD11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"DOI":"10.1007\/s00383-026-06385-8","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:53:39Z","timestamp":1773312819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteomic analysis reveals the pro-proliferative role of the LIN28B\/HMGA2 axis in hepatoblastoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Jia","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangkun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"6385_CR1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","volume":"152","author":"D Sia","year":"2017","unstructured":"Sia D, Villanueva A, Friedman SL, Llovet JM (2017) Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152:745\u2013761","journal-title":"Gastroenterology"},{"key":"6385_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","volume":"59","author":"LG Spector","year":"2012","unstructured":"Spector LG, Birch J (2012) The epidemiology of hepatoblastoma. Pediatr Blood Cancer 59:776\u2013779","journal-title":"Pediatr Blood Cancer"},{"key":"6385_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s10147-013-0624-8","volume":"18","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Inoue T, Horie H (2013) International pediatric liver cancer pathological classification: current trend. Int J Clin Oncol 18:946\u2013954","journal-title":"Int J Clin Oncol"},{"key":"6385_CR4","doi-asserted-by":"publisher","first-page":"E145","DOI":"10.1097\/MPH.0b013e3182459ee8","volume":"34","author":"EM Pereira","year":"2012","unstructured":"Pereira EM, Marion R, Ramesh KH, Kim JS, Ewart M, Ricafort R (2012) Hepatoblastoma in a Mosaic Trisomy 18 Patient. J Pediatr Hematol Oncol 34:E145\u2013E148","journal-title":"J Pediatr Hematol Oncol"},{"key":"6385_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27103","volume":"65","author":"AD Trobaugh-Lotrario","year":"2018","unstructured":"Trobaugh-Lotrario AD, Lopez-Terrada D, Li P, Feusner JH (2018) Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer 65:7","journal-title":"Pediatr Blood Cancer"},{"key":"6385_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00383-002-0734-2","volume":"19","author":"Y Hamada","year":"2003","unstructured":"Hamada Y, Takada K, Fukunaga S, Hioki K (2003) Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy. Pediatr Surg Int 19:112\u2013114","journal-title":"Pediatr Surg Int"},{"key":"6385_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<399::AID-GCC14>3.0.CO;2-X","volume":"25","author":"H Blaker","year":"1999","unstructured":"Blaker H, Hofmann WJ, Rieker RJ, Penzel R, Graf M (1999) Otto, beta-catenin accumulation and mutation of the CTNNBI gene in hepatoblastoma. Gene Chromosomes Cancer 25:399\u2013402","journal-title":"Gene Chromosomes Cancer"},{"key":"6385_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/s-0040-1722645","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Solinas A, Cairo S, Evert M, Chen X, Calvisi DF (2021) Molecular mechanisms of hepatoblastoma. Semin Liver Dis 41:28\u201341","journal-title":"Semin Liver Dis"},{"key":"6385_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D Lopez-Terrada","year":"2009","unstructured":"Lopez-Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang DM, Nguyen Y, Mistretta TA, Margolin J, Finegold MJ (2009) Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK plus precursors. Hum Pathol 40:783\u2013794","journal-title":"Hum Pathol"},{"key":"6385_CR10","first-page":"138","volume":"25","author":"Y Kinoshita","year":"2015","unstructured":"Kinoshita Y, Tanaka S, Souzaki R, Miyoshi K, Kohashi K, Oda Y, Nakatsura T, Taguchi T (2015) Glypican 3 expression in pediatric malignant solid tumors. Eur J Pediatr Surg 25:138\u2013143","journal-title":"Eur J Pediatr Surg"},{"key":"6385_CR11","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.09.76","volume":"7","author":"TC Feng","year":"2019","unstructured":"Feng TC, Zai HY, Jiang W, Zhu Q, Jiang B, Yao L, Li XY, Wang ZM (2019) Survival and analysis of prognostic factors for hepatoblastoma: based on SEER database. Ann Transl Med 7:12","journal-title":"Ann Transl Med"},{"key":"6385_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cld.2018.06.008","volume":"22","author":"K Ng","year":"2018","unstructured":"Ng K, Mogul DB (2018) Pediatric Liver Tumors. Clin Liver Dis 22:753","journal-title":"Clin Liver Dis"},{"key":"6385_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100504","volume":"22","author":"C Cheng","year":"2023","unstructured":"Cheng C, He T, Chen K, Cai Y, Gu Y, Pan L, Duan P, Wu Y, Wu Z (2023) P300 interacted with N-Myc and regulated its protein stability via altering its post-translational modifications in neuroblastoma. Mol Cell Proteomics 22:100504","journal-title":"Mol Cell Proteomics"},{"key":"6385_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"6385_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. The Innovation 2:100141","journal-title":"The Innovation"},{"key":"6385_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","volume":"73","author":"J Carrillo-Reixach","year":"2020","unstructured":"Carrillo-Reixach J, Torrens L, Simon-Coma M, Royo L, Domingo-Sabat M, Abril-Fornaguera J, Akers N, Sala M, Ragull S, Arnal M, Villalmanzo N, Cairo S, Villanueva A, Kappler R, Garrido M, Guerra L, Sabado C, Guillen G, Mallo M, Pineyro D, Vazquez-Vitali M, Kuchuk O, Mateos ME, Ramirez G, Santamaria ML, Mozo Y, Soriano A, Grotzer M, Branchereau S, de Andoin NG, Lopez-Ibor B, Lopez-Almaraz R, Salinas JA, Torres B, Hernandez F, Uriz JJ, Fabre M, Blanco J, Paris C, Bajciova V, Laureys G, Masnou H, Clos A, Belendez C, Guettier C, Sumoy L, Planas R, Jorda M, Nonell L, Czauderna P, Morland B, Sia D, Losic B, Buendia MA, Sarrias MR, Llovet JM, Armengol C (2020) Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol 73:328\u2013341","journal-title":"J Hepatol"},{"key":"6385_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106732","volume":"190","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Rashidi M, Hushmandi K, Ten Hagen TLM, Salimimoghadam S, Taheriazam A, Entezari M, Falahati M (2023) HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response. Pharmacol Res 190:106732","journal-title":"Pharmacol Res"},{"key":"6385_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000301","author":"DJ Park","year":"2020","unstructured":"Park DJ, Sung PS, Kim JH, Lee GW, Jang JW, Jung ES, Bae SH, Choi JY, Yoon SK (2020) EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2019-000301","journal-title":"J Immunother Cancer"},{"key":"6385_CR19","doi-asserted-by":"crossref","unstructured":"Hsieh MH, Wei Y, Li L, Nguyen LH, Lin YH, Yong JM, Sun X, Wang X, Luo X, Knutson SK, Bracken C, Daley GQ, Powers JT, Zhu H (2024) Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteins. J Clin Invest 134","DOI":"10.1172\/JCI165734"},{"key":"6385_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.omtn.2021.09.001","volume":"26","author":"D Rong","year":"2021","unstructured":"Rong D, Wu F, Lu C, Sun G, Shi X, Chen X, Dai Y, Zhong W, Hao X, Zhou J, Xia Y, Tang W, Wang X (2021) M6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Mol Ther Nucleic Acids 26:637\u2013648","journal-title":"Mol Ther Nucleic Acids"},{"key":"6385_CR21","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/hep.32064","volume":"74","author":"G Liu","year":"2021","unstructured":"Liu G, Wang N, Zhang C, Li M, He X, Yin C, Tu Q, Shen X, Zhang L, Lv J, Wang Y, Jiang H, Chen S, Li N, Tao Y, Yin H (2021) Fructose-1,6-bisphosphate aldolase B depletion promotes hepatocellular carcinogenesis through activating insulin receptor signaling and lipogenesis. Hepatology 74:3037\u20133055","journal-title":"Hepatology"},{"key":"6385_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1615\/CritRevEukaryotGeneExpr.2014010087","volume":"24","author":"J Wu","year":"2014","unstructured":"Wu J, Dan C, Zhao HB, Xiao CX, Liu YP, Si LJ, Ren JL, Guleng B (2014) Aldob acts as a novel HBsAg-binding protein and its coexistence inhibits cisplatin-induced HepG2 cell apoptosis. Crit Rev Eukaryot Gene Expr 24:181\u2013191","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"6385_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41574-018-0031-3","volume":"14","author":"I Leong","year":"2018","unstructured":"Leong I (2018) Aldob promotes liver metastases development. Nat Rev Endocrinol 14:380","journal-title":"Nat Rev Endocrinol"},{"key":"6385_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2019.10.012","volume":"31","author":"P Huangyang","year":"2020","unstructured":"Huangyang P, Li F, Lee P, Nissim I, Weljie AM, Mancuso A, Li B, Keith B, Yoon SS, Simon MC (2020) Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis. Cell Metab 31:174\u2013188e177","journal-title":"Cell Metab"},{"key":"6385_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6766787","volume":"2022","author":"L Wang","year":"2022","unstructured":"Wang L, Wang J, Shen Y, Zheng Z, Sun J (2022) Fructose-1,6-bisphosphatase 2 inhibits oral squamous cell carcinoma tumorigenesis and glucose metabolism via downregulation of c-Myc. Oxid Med Cell Longev 2022:6766787","journal-title":"Oxid Med Cell Longev"},{"key":"6385_CR26","doi-asserted-by":"publisher","first-page":"60414","DOI":"10.18632\/oncotarget.19578","volume":"8","author":"YC Wang","year":"2017","unstructured":"Wang YC, Li J, Guo SX, Ouyang YS, Yin LY, Liu SS, Zhao ZP, Yang JL, Huang WJ, Qin H, Zhao X, Ni B, Wang HZ (2017) Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma. Oncotarget 8:60414\u201360428","journal-title":"Oncotarget"},{"key":"6385_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083869","volume":"8","author":"TF Wu","year":"2013","unstructured":"Wu TF, Jia J, Xiong XP, He HJ, Bu LL, Zhao ZL, Huang CF, Zhang WF (2013) Increased expression of Lin28B associates with poor prognosis in patients with oral squamous cell carcinoma. PLoS One 8:9","journal-title":"PLoS One"},{"key":"6385_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2016.04.033","volume":"165","author":"S Kugel","year":"2016","unstructured":"Kugel S, Sebastian C, Fitamant J, Ross KN, Saha SK, Jain E, Gladden A, Arora KS, Kato Y, Rivera MN, Ramaswamy S, Sadreyev RI, Goren A, Deshpande V, Bardeesy N, Mostoslavsky R (2016) SIRT6 suppresses pancreatic cancer through control of Lin28b. Cell 165:1401\u20131415","journal-title":"Cell"},{"key":"6385_CR29","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1038\/onc.2011.131","volume":"30","author":"CE King","year":"2011","unstructured":"King CE, Wang L, Winograd R, Madison BB, Mongroo PS, Johnstone CN, Rustgi AK (2011) LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene 30:4185\u20134193","journal-title":"Oncogene"},{"key":"6385_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2017.00031","volume":"8","author":"J Balzeau","year":"2017","unstructured":"Balzeau J, Menezes MR, Cao SY, Hagan JP (2017) The LIN28\/let-7 pathway in cancer. Front Genet 8:1\u201316","journal-title":"Front Genet"},{"key":"6385_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0402-5","author":"TZ Wang","year":"2015","unstructured":"Wang TZ, Wang GY, Hao DP, Liu X, Wang D, Ning N, Li XB (2015) Aberrant regulation of the LIN28A\/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-015-0402-5","journal-title":"Mol Cancer"},{"key":"6385_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ccr.2014.06.018","volume":"26","author":"LH Nguyen","year":"2014","unstructured":"Nguyen LH, Robinton DA, Seligson MT, Wu LW, Li L, Rakheja D, Comerford SA, Ramezani S, Sun XK, Parikh MS, Yang EH, Powers JT, Shinoda G, Shah SP, Hammer RE, Daley GQ, Zhu H (2014) Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell 26:248\u2013261","journal-title":"Cancer Cell"},{"key":"6385_CR33","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1590\/1414-431x20154400","volume":"48","author":"BL Xu","year":"2015","unstructured":"Xu BL, Zhao QZ, Gao XY, Hou GJ (2015) Effect of estradiol and bisphenol A on human hepatoblastoma cell viability and telomerase activity. Braz J Med Biol Res 48:1004\u20131009","journal-title":"Braz J Med Biol Res"},{"key":"6385_CR34","first-page":"D845","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero J, Ramirez-Anguita JM, Sauch-Pitarch J, Ronzano F, Centeno E, Sanz F, Furlong LI (2020) The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 48:D845\u2013D855","journal-title":"Nucleic Acids Res"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-026-06385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-026-06385-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-026-06385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:53:51Z","timestamp":1773312831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-026-06385-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6385"],"URL":"https:\/\/doi.org\/10.1007\/s00383-026-06385-8","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"All patient samples were obtained with Xinhua hospital\u2019s approval of Ethics Committees with written informed consent provided by all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}}],"article-number":"150"}}